SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-004190
Filing Date
2024-03-28
Accepted
2024-03-28 11:01:11
Documents
152
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F casi-20231231x20f.htm   iXBRL 20-F 3613079
2 EX-1.1 casi-20231231xex1d1.htm EX-1.1 1401894
3 EX-2.1 casi-20231231xex2d1.htm EX-2.1 35204
4 EX-4.29 casi-20231231xex4d29.htm EX-4.29 234999
5 EX-4.37 casi-20231231xex4d37.htm EX-4.37 1133847
6 EX-4.38 casi-20231231xex4d38.htm EX-4.38 328356
7 EX-4.39 casi-20231231xex4d39.htm EX-4.39 44235
8 EX-4.40 casi-20231231xex4d40.htm EX-4.40 343978
9 EX-4.41 casi-20231231xex4d41.htm EX-4.41 321863
10 EX-4.42 casi-20231231xex4d42.htm EX-4.42 142619
11 EX-4.43 casi-20231231xex4d43.htm EX-4.43 130770
12 EX-4.44 casi-20231231xex4d44.htm EX-4.44 123313
13 EX-4.45 casi-20231231xex4d45.htm EX-4.45 321457
14 EX-4.46 casi-20231231xex4d46.htm EX-4.46 93556
15 EX-4.47 casi-20231231xex4d47.htm EX-4.47 124422
16 EX-4.48 casi-20231231xex4d48.htm EX-4.48 48132
17 EX-8.1 casi-20231231xex8d1.htm EX-8.1 2484
18 EX-11.1 casi-20231231xex11d1.htm EX-11.1 52513
19 EX-12.1 casi-20231231xex12d1.htm EX-12.1 12715
20 EX-12.2 casi-20231231xex12d2.htm EX-12.2 13206
21 EX-13.1 casi-20231231xex13d1.htm EX-13.1 6881
22 EX-13.2 casi-20231231xex13d2.htm EX-13.2 7044
23 EX-15.1 casi-20231231xex15d1.htm EX-15.1 2044
24 EX-97.1 casi-20231231xex97d1.htm EX-97.1 45976
25 GRAPHIC casi-20231231x20f009.jpg GRAPHIC 10639
26 GRAPHIC casi-20231231x20f010.jpg GRAPHIC 6382
27 GRAPHIC casi-20231231x20f011.jpg GRAPHIC 30518
28 GRAPHIC casi-20231231xex11d1001.jpg GRAPHIC 9474
29 GRAPHIC casi-20231231xex2d1_ag001.jpg GRAPHIC 352612
30 GRAPHIC casi-20231231xex2d1_b001.jpg GRAPHIC 3486
31 GRAPHIC casi-20231231xex4d41005.jpg GRAPHIC 707
  Complete submission text file 0001558370-24-004190.txt   21878590

Data Files

Seq Description Document Type Size
32 EX-101.SCH casi-20231231.xsd EX-101.SCH 112247
33 EX-101.CAL casi-20231231_cal.xml EX-101.CAL 101630
34 EX-101.DEF casi-20231231_def.xml EX-101.DEF 528168
35 EX-101.LAB casi-20231231_lab.xml EX-101.LAB 738942
36 EX-101.PRE casi-20231231_pre.xml EX-101.PRE 762555
156 EXTRACTED XBRL INSTANCE DOCUMENT casi-20231231x20f_htm.xml XML 2935027
Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Filer) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41666 | Film No.: 24795197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)